Genetic Technology Alert. Nanoparticle-Based Wound Therapy Developed; Cancer Drug Found To Be Effective in Treating Arterio-Venous Malformations; Gene Responsible for Insulin Resistance Discovered

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles a nanoparticle-based wound therapy, a cancer drug found to be effective in treating arterio-venous malformations, and a gene responsible for insulin resistance.

Table of Contents

Genetic Technology Alert. Nanoparticle-Based Wound Therapy Developed; Cancer Drug Found To Be Effective in Treating Arterio-Venous Malformations; Gene Responsible for Insulin Resistance DiscoveredIn This Issue1. NANOPARTICLE-BASED WOUND THERAPY DEVELOPED2. CANCER DRUG FOUND TO BE EFFECTIVE IN TREATING ARTERIO-VENOUS MALFORMATIONS3. GENE RESPONSIBLE FOR INSULIN RESISTANCE DISCOVERED4. GLOBAL PATENTS ON TREATMENT OPTIONS FOR PRADER-WILLI SYNDROME




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.